Open tender · Germany · Contract notice
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Triptorelin (ATC-Code: L02AE04 und H01CA07) .
AOK Niedersachsen. Die Gesundheitskasse.
AOK Niedersachsen. Die Gesundheitskasse. in Germany is inviting bids for “Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Triptorelin (ATC-Code: L02AE04 und…”. Bids close on 27 October 2027. To qualify, bidders need at least one similar completed work and Pharmazeutischer Unternehmer status.
The work
Conclusion of a non-exclusive discount contract for the active substance Triptorelin (ATC-Code: L02AE04 and H01CA07) from 01.01.2026 to 31.12.2027.
- Contract must be for Triptorelin (ATC-Code: L02AE04 and H01CA07).
- Contract must be non-exclusive.
- Contract must be concluded within the open-house model.
Key facts
- Contract period
- Up to 24 months, ending no later than 31.12.2027.
- Evaluation
- This is not a public procurement in the sense of Directive 2014/24/EU.
What it takes to qualify
Worth a closer look
- The tender document is not a public procurement in the sense of Directive 2014/24/EU.
- The publication is in the Supplement zum Amtsblatt der Europäischen Union.
- The procedure is referred to as an 'offenes Verfahren' due to the publication form.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
- Being a pharmaceutical entrepreneur with a seat in the AMG area, EU, or EEA.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documentsTo be requested from AOK Niedersachsen and submitted by the deadline.